Menu
Search
|

Menu

Close
X

Cisen Pharmaceutical Co Ltd 603367.SS (Shanghai Stock Exchange)

17.26 CNY
+0.29 (+1.71%)
As of Sep 20
chart
Previous Close 16.97
Open 17.07
Volume 1,854,000
3m Avg Volume 6,042,037
Today’s High 17.37
Today’s Low 17.00
52 Week High 32.73
52 Week Low 13.99
Shares Outstanding (mil) 453.35
Market Capitalization (mil) 7,770.47
Forward P/E 15.33
Dividend (Yield %) 0.16 ( 0.93 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, CNY)
FY18
1,872
FY17
3,664
FY16
1,369
EPS (CNY)
FY18
0.519
FY17
1.177
FY16
0.446
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
15.33
32.65
Price to Sales (TTM)
vs sector
2.17
6.44
Price to Book (MRQ)
vs sector
2.00
3.90
Price to Cash Flow (TTM)
vs sector
--
23.45
Total Debt to Equity (MRQ)
vs sector
0.77
14.01
LT Debt to Equity (MRQ)
vs sector
0.00
11.19
Return on Investment (TTM)
vs sector
14.31
12.72
Return on Equity (TTM)
vs sector
15.17
14.84

EXECUTIVE LEADERSHIP

Zhenxin Du
Chairman of the Board, General Manager, Since
Salary: --
Bonus: --
Yanzhen Han
Deputy General Manager, Since
Salary: --
Bonus: --
Liushan Hao
Deputy General Manager, Since
Salary: --
Bonus: --
Honghui Sun
Secretary of the Board, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.16 Tongji Road, Hi-tech Zone
JINING   SDG   272073

Phone: +86537.2989906

Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.

SPONSORED STORIES